Company news
Foresee Pharmaceuticals Co., Ltd. news in 2024
Foresee Pharmaceuticals Co., Ltd.'s news releases, calls and decks from 2024, newest first.
Foresee Pharmaceuticals Announces Several New Developments Related to its SIF Long-Acting Injectable (LAI) Technologies - Solidifying its Position as a Leader in Complex Long-Acting Injectable Products
August 12, 2024
Foresee Pharmaceuticals Receives Positive Recommendation from DSMB to Continue the Casppian Study, a Phase 3 Clinical Trial of Leuprolide Injectable Emulsion for the Treatment of CPP
April 2, 2024